Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I like the diversity of topics that MedCity News covers – ranging from devices to policy to start-up companies. Always something interesting to find.”

Robert J. Szczerba, Ph.D., CEO, X Tech Ventures


Sign up for our daily newsletter


Forest Laboratories submits Cariprazine drug application

November 28, 2012 2:17 am by | 0 Comments

BUDAPEST (Reuters) - Forest Laboratories has recently submitted a new drug application to the U.S. Food and Drug Administration (FDA) for antipsychotic drug Cariprazine, its Hungarian partner Richter said in a statement on Wednesday.

Cariprazine was discovered by Richter and is licensed to Forest Laboratories Inc. in the U.S. and Canada.

Richter said Forest's application to the FDA was submitted for the treatment of both schizophrenia and manic or mixed episodes associated with bipolar I disorder.

(Reporting by Gergely Szakacs; Editing by David Goodman)

Advertisement

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments